Last reviewed · How we verify

NCT03986983: SWT

Shockwave Therapy (SWT)

Completed NA Last updated 11 December 2019
What this trial tests

NA trial testing Shockwave therapy in Gynoid Lipodystrophy in 45 participants. Completed in 26 July 2019.

Timeline
25 June 2019
Primary endpoint
26 July 2019
26 July 2019

Quick facts

Lead sponsorEscola Superior de Tecnologia da Saúde do Porto
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment45
Start date25 June 2019
Primary completion26 July 2019
Estimated completion26 July 2019
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Escola Superior de Tecnologia da Saúde do Porto

Who can join

Adults 18 to 35, female only, with Gynoid Lipodystrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the present study is to evaluate the effects of six sessions of aerobic exercise associated with shock waves therapy in the severity of gynoid lipodystrophy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of shock wave therapy associated with aerobic exercise on cellulite: A randomized controlled trial.
    Troia S, Moreira AM, Pisco D, Noites A, et al · · 2021 · cited 5× · PMID 33053245 · DOI 10.1111/jocd.13791

Verify or expand the search:

Other trials of Shockwave therapy

Trials testing the same drug.

Other Escola Superior de Tecnologia da Saúde do Porto trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03986983.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing